Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Abnormal expression of PI3K isoforms in patients with tobacco-related oral squamous cell carcinoma.

Garg R, Kapoor V, Mittal M, Singh MK, Shukla NK, Das SN.

Clin Chim Acta. 2013 Feb 1;416:100-6. doi: 10.1016/j.cca.2012.11.027.

PMID:
23228846
2.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
3.

Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer.

Kaur J, Sawhney M, Dattagupta S, Shukla NK, Srivastava A, Ralhan R.

BMC Cancer. 2010 Apr 28;10:168. doi: 10.1186/1471-2407-10-168.

4.

Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.

De Maria S, Pannone G, Bufo P, Santoro A, Serpico R, Metafora S, Rubini C, Pasquali D, Papagerakis SM, Staibano S, De Rosa G, Farina E, Emanuelli M, Santarelli A, Mariggiò MA, Lo Russo L, Lo Muzio L.

J Cancer Res Clin Oncol. 2009 Jan;135(1):107-16. doi: 10.1007/s00432-008-0433-z.

PMID:
18642030
5.

Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.

Mallick S, Patil R, Gyanchandani R, Pawar S, Palve V, Kannan S, Pathak KA, Choudhary M, Teni TR.

J Pathol. 2009 Feb;217(3):398-407. doi: 10.1002/path.2459.

PMID:
19009587
6.

Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T.

Oncol Rep. 2009 Nov;22(5):1173-9.

PMID:
19787237
7.

Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.

Mishra R, Das BR.

Arch Oral Biol. 2009 Oct;54(10):917-23. doi: 10.1016/j.archoralbio.2009.07.003.

PMID:
19679297
8.

Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.

Vigneswaran N, Baucum DC, Wu J, Lou Y, Bouquot J, Muller S, Zacharias W.

BMC Cancer. 2007 Jun 25;7:108.

10.

Midkine as a prognostic biomarker in oral squamous cell carcinoma.

Ota K, Fujimori H, Ueda M, Shiniriki S, Kudo M, Jono H, Fukuyoshi Y, Yamamoto Y, Sugiuchi H, Iwase H, Shinohara M, Ando Y.

Br J Cancer. 2008 Aug 19;99(4):655-62. doi: 10.1038/sj.bjc.6604539.

11.

Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.

Chen CH, Lin YS, Lin CC, Yang YH, Ho YP, Tsai CC.

J Oral Pathol Med. 2004 Nov;33(10):589-94.

PMID:
15482324
12.

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Chakraborty S, Mohiyuddin SM, Gopinath KS, Kumar A.

BMC Cancer. 2008 Jun 6;8:163. doi: 10.1186/1471-2407-8-163.

13.

Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.

Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY.

Arch Oral Biol. 2007 Nov;52(11):1079-87.

PMID:
17612501
14.

ORAOV1 is amplified in oral squamous cell carcinoma.

Xavier FC, Rodini CO, Paiva KB, Destro MF, Severino P, Moyses RA; Head and Neck Genome Project GENCAPO., Tajara EH, Nunes FD.

J Oral Pathol Med. 2012 Jan;41(1):54-60. doi: 10.1111/j.1600-0714.2011.01053.x.

PMID:
21623924
15.

Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.

Ries J, Mollaoglu N, Vairaktaris E, Neukam FW, Nkenke E.

Anticancer Res. 2009 Dec;29(12):5125-30.

16.

Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer.

Papagerakis S, Shabana AH, Pollock BH, Papagerakis P, Depondt J, Berdal A.

Hum Pathol. 2009 Sep;40(9):1320-9. doi: 10.1016/j.humpath.2009.02.002.

PMID:
19386346
17.

Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.

Zhang L, Pan HY, Zhong LP, Wei KJ, Yang X, Li J, Shen GF, Zhang Z.

J Oral Pathol Med. 2010 Jul;39(6):470-6. doi: 10.1111/j.1600-0714.2009.00869.x.

PMID:
20149058
18.

Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.

Kato H, Uzawa K, Onda T, Kato Y, Saito K, Nakashima D, Ogawara K, Bukawa H, Yokoe H, Tanzawa H.

Int J Oncol. 2006 Apr;28(4):873-81.

PMID:
16525636
19.

[Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].

Lu XZ, Yin XM, Feng YY, Duan LQ, Chen WT, Zhang CP.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jul;28(7):1165-7. Chinese.

20.

Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.

Silva TA, Ribeiro FL, Oliveira-Neto HH, Watanabe S, Alencar Rde C, Fukada SY, Cunha FQ, Leles CR, Mendonça EF, Batista AC.

Oncol Rep. 2007 Nov;18(5):1107-13.

PMID:
17914560
Items per page

Supplemental Content

Support Center